Suchergebnisse - "TAMBY JEAN-FRANCOIS"

PubPharm (30)

1

TREATMENT OF ATRIAL DYSFUNCTION

enthalten in: Europäisches Patentamt | 2023

von TAMBY JEAN-FRANCOIS | EDELBERG JAY M | KURIO GREGORY HOWARD TAKEO | +7

2

TREATMENT OF ATRIAL DYSFUNCTION

enthalten in: Europäisches Patentamt | 2023

von TAMBY JEAN-FRANCOIS | EDELBERG JAY M | KURIO GREGORY HOWARD TAKEO | +7

3

심방 기능 부전의 치료

enthalten in: Europäisches Patentamt | 2023

von TAMBY JEAN FRANCOIS | EDELBERG JAY M | KURIO GREGORY HOWARD TAKEO | +7

4

Treatment of atrial dysfunction

enthalten in: Europäisches Patentamt | 2023

von TAMBY JEAN-FRANCOIS | EDELBERG JAY M | KURIO GREGORY HOWARD TAKEO | +7

5

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

enthalten in: Circulation | 2022

von Hagström, E. | Steg, P. | Szarek, M. | +117

CommentIn: Circulation. 2022 Aug 30;146(9):673-675. - PMID 36037269

6

TREATMENT OF SYSTOLIC DYSFUNCTION AND HEART FAILURE WITH REDUCED EJECTION FRACTION WITH THE COMPOUND (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE

enthalten in: Europäisches Patentamt | 2022

von TAMBY JEAN-FRANCOIS | YANG CHUN | CARLSON TIMOTHY

7

TREATMENT OF SYSTOLIC DYSFUNCTION AND HEART FAILURE WITH REDUCED EJECTION FRACTION WITH THE COMPOUND(R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE

enthalten in: Europäisches Patentamt | 2022

von TAMBY JEAN-FRANCOIS | YANG CHUN | CARLSON TIMOTHY

8

Treatment of cardiac dysfunction and heart failure with reduced ejection fraction with compound (r)-4-(1-((3-(difluoromethyl)-1-methyl-1h-pyrazol-4-yl) sulfonyl)-1-fluoroethyl)-n-(isoxazol-3-yl) piperidine-1-carboxamide

enthalten in: Europäisches Patentamt | 2022

von TAMBY JEAN-FRANCOIS | YANG CHUN | KARLSSON TOMAS

9

화합물 (R)-4--1-메틸-1H-피라졸-4-일)술포닐)-1-플루오로에틸)-N-피페리딘-1-카르복스아미드를 사용한 수축기 기능장애 및 감소된 박출 계수를 가진 심부전의 치료

enthalten in: Europäisches Patentamt | 2022

von TAMBY JEAN FRANCOIS | YANG CHUN | CARLSON TIMOTHY

10

Treatment of systolic dysfunction and heart failure with reduced ejection fraction with the compound(R)-4-(1-((3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)sulfonyl)-1-fluoroethyl)-N-(isoxazol-3-yl)piperidine-1-carboxamide

enthalten in: Europäisches Patentamt | 2021

von TAMBY JEAN-FRANCOIS | YANG CHUN | CARLSON TIMOTHY